Implementing a Screening Tool for Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative

被引:29
|
作者
Traxler, L. Brannon [1 ]
Martin, Monique L. [2 ]
Kerber, Alice S. [2 ]
Bellcross, Cecelia A. [3 ]
Crane, Barbara E. [4 ]
Green, Victoria [5 ]
Matthews, Roland [6 ]
Paris, Nancy M. [2 ]
Gabram, Sheryl G. A. [1 ,7 ]
机构
[1] Emory Univ, Dept Surg, Atlanta, GA 30322 USA
[2] Georgia Ctr Oncol Res & Educ, Atlanta, GA USA
[3] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA
[4] Georgia Dept Publ Hlth, Atlanta, GA USA
[5] Emory Univ, Dept Obstet & Gynecol, Atlanta, GA 30322 USA
[6] Morehouse Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30310 USA
[7] Grady Mem Hosp, Atlanta, GA USA
关键词
RECOMMENDATION STATEMENT; WOMEN; SUSCEPTIBILITY; MODEL;
D O I
10.1245/s10434-014-3921-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The Georgia Breast Cancer Genomic Health Consortium is a partnership created with funding from the Centers for Disease Control and Prevention (CDC) to the Georgia Department of Public Health to reduce cancer disparities among high-risk minority women. The project addresses young women at increased risk for hereditary breast and ovarian cancer (HBOC) syndrome through outreach efforts. Methods. The consortium provides education and collects surveillance data using the breast cancer genetics referral screening tool (B-RST) available at www.BreastCancerGeneScreen.org. The HBOC educational protocol was presented to 73 staff in 6 public health centers. Staff used the tool during the collection of medical history. Further family history assessments and testing for mutations in the BRCA1/2 genes were facilitated if appropriate. Results. Data was collected from November 2012 through December 2013, including 2,159 screened women. The majority of patients identified as black/African American and were 18-49 years old. Also, 6.0 % (n = 130) had positive screens, and 60.9 % (n = 67) of the 110 patients who agreed to be contacted provided a detailed family history. A total of 47 patients (42.7 %) met National Comprehensive Cancer Network guidelines when family history was clarified. Fourteen (12.7 %) underwent genetic testing; 1 patient was positive for a BRCA2 mutation, and 1 patient was found to carry a variant of uncertain significance. Conclusions. The introduction of genomics practice within public health departments has provided access to comprehensive cancer care for uninsured individuals. The successful implementation of the B-RST into public health centers demonstrates the opportunity for integration of HBOC screening into primary care practices.
引用
收藏
页码:3342 / 3347
页数:6
相关论文
共 50 条
  • [21] Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer
    Szender, J. Brian
    Kaur, Jasmine
    Clayback, Katherine
    Hutton, Mollie L.
    Mikkelson, June
    Odunsi, Kunle
    Dresbold, Cara
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (01) : 26 - 33
  • [22] Identification of women at risk of hereditary breast–ovarian cancer among participants in a population-based breast cancer screening
    Luigina Bonelli
    Ivana Valle
    Ivana Rebora
    Paola Ricci
    Lidia Biocchi
    Giovanna Bruschi
    Sabrina Parodi
    Carla Bruzzone
    Liliana Varesco
    [J]. Familial Cancer, 2022, 21 : 309 - 318
  • [23] Breast and Ovarian Cancer Hereditary Risk Assessment Program
    Wallace, Charlenc
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (05): : 512 - 512
  • [24] Laboratory identification of hereditary risk of breast and ovarian cancer
    Frank, TS
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (03) : 289 - 294
  • [25] Value of a genetics clinic evaluation in identifying women at risk for hereditary breast-ovarian cancer syndrome
    Hinshaw, Jesse C.
    Zhao, Lue-Ping
    Brimm, John E.
    Payne, Thomas H.
    Hisama, Fuki M.
    [J]. JOURNAL OF GENETIC COUNSELING, 2021, 30 (06) : 1591 - 1597
  • [26] Hereditary breast cancer: screening and risk reducing surgery
    Renzulli, Matteo
    Zanotti, Simone
    Clemente, Alfredo
    Mineo, Giangaspare
    Tovoli, Francesco
    Reginelli, Alfonso
    Barile, Antonio
    Cappabianca, Salvatore
    Taffurelli, Mario
    Golfieri, Rita
    [J]. GLAND SURGERY, 2019, 8 : S142 - S149
  • [27] Mutation screening of Bulgarian hereditary breast and ovarian cancer patients with multi-gene cancer panel
    Mitkova, A.
    Dodova, R.
    Pencheva, D.
    Vlahova, A.
    Taushanova-Hadjieva, M.
    Valev, S.
    Timcheva, K.
    Christova, S.
    Mitev, V.
    Kaneva, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S37 - S37
  • [28] Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients
    Jarhelle, Elisabeth
    Stensland, Hilde Monica Frostad Riise
    Hansen, Geir Asmund Myge
    Skarsfjord, Siri
    Jonsrud, Christoffer
    Ingebrigtsen, Monica
    Stromsvik, Nina
    Van Ghelue, Marijke
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients
    Elisabeth Jarhelle
    Hilde Monica Frostad Riise Stensland
    Geir Åsmund Myge Hansen
    Siri Skarsfjord
    Christoffer Jonsrud
    Monica Ingebrigtsen
    Nina Strømsvik
    Marijke Van Ghelue
    [J]. Scientific Reports, 9
  • [30] Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening
    Bonelli, Luigina
    Valle, Ivana
    Rebora, Ivana
    Ricci, Paola
    Biocchi, Lidia
    Bruschi, Giovanna
    Parodi, Sabrina
    Bruzzone, Carla
    Varesco, Liliana
    [J]. FAMILIAL CANCER, 2022, 21 (03) : 309 - 318